Methylenetetrahydrofolate reductase (MTHFR) and methionine synthase reductase (MTRR) gene polymorphisms have been implicated in the etiology of CHD and its associated mortality through their influence on homocysteine metabolism. This evidence concerns the gene MTHFR and coronary artery disorder.